Watch DDW’s Neuroscience Showcase On Demand
In this free online event at 3pm BST on 24 October, hosted by DDW and co-sponsored by ApconiX and AxoSim, leading industry figures outline the areas of opportunity and challenges in the neuroscience drug discovery & development sector.
The showcase includes a panel discussion looking at the use of new drug discovery and development technology, concepts and tools in neuroscience, as well what the future looks like for neuroscience therapies. The panel consists of Professor Ruth Roberts, Co-founder and Director of Safety Science at ApconiX, Dr Mark Treherne, Director and Chairman of Talisman Therapeutics, and Janet Sasso, Information Scientist at CAS.
The showcase includes presentations from Dr Sheldon Preskorn, SVP of Neuroscience at Dr Vince Clinical Research, and from Dr Kiri Granger, CSO of Monument Therapeutics. Dr Preskorn’s presentation highlights the accelerating evolution of psychiatric treatment development from one dependent on chance observations to more sophisticated and less risky molecular biology approaches. Dr Granger’s presentation covers the company’s use of precision medicine to develop effective treatment options for areas of high unmet need in psychiatry and neurology.
What you will learn:
- Where is the opportunity in the neuroscience market?
- How to uncover the best research tools to boost the development of new treatments
- How to recognise and tackle barriers in neuroscience research
- What are the technologies that can help create efficiencies and get to market faster?
- What does the future hold for neuroscience?
In addition, the showcase features product presentations from sponsors ApconiX and AxoSim that give the audience the opportunity to learn about the latest technologies driving neuroscience drug discovery and development.